Going forward, PolyNovo and Beta Cell are in collaboration discussions to accelerate research anddevelopment pathways to ensure PolyNovo’s technology can play a major role in the cell therapy market space which is estimated to be USD $34 Billion by 2034
Wow there must be other applications for this cell therapy besides Type 1 Diabetes.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.035(2.64%) |
Mkt cap ! $891.1M | |||
| Open | High | Low | Value | Volume |
| $1.33 | $1.35 | $1.29 | $2.596M | 1.984M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 66524 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 11567 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PNV (ASX) Chart |